Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.
About this institution
Publications Show all
Eplerenone for the treatment of chronic central serous chorioretinopathy: 3-year clinical experience.
...Published in British Journal of Ophthalmology
The efficacy of mineralocorticoid receptor antagonist eplerenone to treat chronic central serous chorioretinopathy (CSCR) has been established. However, previous studies have been limited by small cohort size and short follow-up duration. This study aims to report 3-year clinical outcomes of patients treated with eplerenone for chronic CSCR. Instit...
